Clearstead Advisors’s Nkarta NKTX Stock Holding History

Clearstead Advisors’s Portfolio NKTX Stock Details NKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$216	Buy	+76	New	+$214	﹤0.01%	3185
2025 Q3	–	Sell	-11	Closed	-$19	–	3188
2025 Q2	$19	Buy	+11	New	+$20	﹤0.01%	2711

Other funds holding NKTX

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

GSK plc London $602M AUM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Clearstead Advisors's NKTX Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Nkarta (NKTX) in Q2 2026: 76 shares worth $216. The stake represents ﹤0.01% of the portfolio and ranks #3185 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in NKTX as recently as Q2 2025.

Clearstead Advisors first reported a position in NKTX in Q2 2025 and has held it in 2 quarters since. 135 funds tracked by Wall St. Rank hold NKTX as of Q2 2026.

Clearstead Advisors held 76 shares of Nkarta worth $216 as of Q2 2026.
Nkarta was a new Clearstead Advisors position in Q2 2026.
Nkarta made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3185 holding.
Clearstead Advisors first reported a position in Nkarta in Q2 2025 and has held it in 2 quarters since.
135 funds tracked by Wall St. Rank held Nkarta as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.